RSS

Tufts Center for the Study of Drug Development

A new study from Tufts Center for the Study of Drug Development highlights the need to transform clinical data management practices to enable risk-based approaches and reveals the root causes for delays and inefficiencies impacting trial timelines Read more

News

A new survey report from Tufts Centre for the Study of Drug Development has highlighted that life sciences companies plan to use a greater range of patient data in clinical trials for more accurate decision-making. Read more

Analysis

Findings from a modelling study performed by Tufts Center for the Study of Drug Development (CSDD) have revealed there are financial benefits of using single-source outsourcing partners versus a multivendor development and manufacturing model. Read more

News

According to a survey released by Tufts Center for the Study of Drug Development, ‘2017 eClinical Landscape Study’, the length of time it takes companies to build and release a clinical study database is having a negative effect on trial completion Read more

Analysis